	Predicting Invasiveness of Lung Adenocarcinoma from Chest CT with Few-shot Vision-Language Ternary Classification Model. NPJ Digit Med Xu N, He Q, Wang L, Zhang Z, Sheng Q, Gao S, Zhang S, Chen B, Sun J, Zhang Z, Zhang J, Qiu J, Wang Y, Liu G, Li E, Tian M, Wang H, Yu J, Dong Y, Gao S, Chen S, Yang F, Chang Z, Dong Y, Zhang L, Song J. PMID: 41422131 [PubMed - as supplied by publisher]
	Bridging the gap in lung cancer: A comprehensive global strategy for change. Eur J Cancer Syrigos KN, Bussell ME, Al-Shamsi HO, Khorshid O, Herbst RS, Agelaki S, Leighl N, Hirsch F, Wakelee H. PMID: 41421886 [PubMed - as supplied by publisher]
	Deep Learning-Based Classification of Lung Adenocarcinoma Subtypes in Histopathological Images Using DS-EffNet. Hum Pathol Jiang P, Chen W, Song X, Li X. PMID: 41421723 [PubMed - as supplied by publisher]
	Bidirectional Role of Neutrophils in Lung Cancer: Mechanisms and Therapeutic Implications. Crit Rev Oncol Hematol Wang J, Zhang M, Cui Z, Qu J, Chang R. PMID: 41421459 [PubMed - as supplied by publisher]
	To ablate or not to ablate? Outcomes of local ablative treatments (LAT) for Oncogene Addicted (OA) Oligo-Metastatic (OM) Non-Small Cell Lung Cancer (NSCLC): a Systematic Review. Crit Rev Oncol Hematol Citarella F, Fragale C, Fiorenti M, Di Guglielmo ML, Mindicini N, Cortellini A, Russo A, Bronte G. PMID: 41421458 [PubMed - as supplied by publisher]
	A phase II, multicenter, open-label, single-arm study of berzosertib plus topotecan in patients with relapsed platinum-resistant small-cell lung cancer (DDRiver SCLC 250). ESMO Open Navarro A, Thomas A, Cheng Y, Chen Y, Reguart N, Yoshida T, Cousin S, Dong X, Yamamoto N, Cappuzzo F, Hallwachs R, Bolleddula J, Sarholz B, Grombacher T, Otte M, Gounaris I, Ferrer J, Moulin C, Paz-Ares L. PMID: 41421295 [PubMed - as supplied by publisher]
	A pathomics model for predicting response to chemo-immunotherapy in lung squamous cell carcinoma: A multicenter study. Lung Cancer Wang D, Mu S, Zhang M, Tao G, Wang S, Shen Y, Xiao G, Zhang X, Han B, Cheng L, Zhong H, Nie W. PMID: 41421034 [PubMed - as supplied by publisher]
	Identifying eligible patients for the Australian national lung cancer screening program in primary care: A cross-sectional study using clinical decision support systems and evaluating PLCO(m2012) data quality. Lung Cancer Mendonça L, Onwuka S, York S, Martinez-Gutierrez J, Emery J, Paul C, Manski-Nankervis JA, Rankin NM. PMID: 41421033 [PubMed - as supplied by publisher]
	Liquid Biopsy for EGFR Mutation Detection in NSCLC: Evaluation of Plasma ctDNA and Comparison with Plasma exoDNA. Iran Biomed J Mashayekhi P, Omrani MD, Dehghanifard A, Khosravi A, Jahani MM, Khosravi N. PMID: 41420326 [PubMed - indexed for MEDLINE]
	CT based quantification of intratumoral and peritumoral heterogeneity for diagnosing lymphovascular invasion for early stage non-small cell lung cancer. BMC Med Imaging Long Y, Zhang H, Guo Y, Gan T, Wang J, Li T, Zhang K, Chen J, Yang L, Liao M, Xiao F. PMID: 41420150 [PubMed - in process]
	Guanylate-binding proteins score and a CBFA2T3-included risk model define immune microenvironment and chemosensitivity in lung adenocarcinoma. Eur J Med Res Shi Z, Shen Y, Liu X, Zhang S. PMID: 41419978 [PubMed - as supplied by publisher]
	Biomarker study on pneumonitis in durvalumab maintenance therapy after chemoradiotherapy for stage III non-small cell lung cancer. BMC Cancer Yano R, Tokito T, Murotani K, Murata D, Tsuneyoshi S, Ishii H, Azuma K, Hoshino T. PMID: 41419873 [PubMed - as supplied by publisher]
	Clinical impact of continuing osimertinib beyond progression versus best supportive care in EGFR-mutated advanced non-small cell lung cancer: a multi-institutional retrospective study. BMC Cancer Oi I, Fujita K, Imakita T, Okada Y, Yoshimura S, Fujimoto N, Toyama S, Watanabe A, Ito T, Kaku R, Kanai O, Ohuchi M, Noguchi T, Tsukino M, Sawai S, Tanizawa K. PMID: 41419830 [PubMed - as supplied by publisher]
	Harnessing Native-Resolution 2D Embeddings for Lung Cancer Classification: A Feasibility Study with the RAD-DINO Self-supervised Foundation Model. J Imaging Inform Med Hoq ME, Tarbox L, Johann D Jr, Larson-Prior L, Prior F. PMID: 41419702 [PubMed - as supplied by publisher]
	Consensus on the Diagnosis and Treatment of Unresectable Stage III Driver Gene-Positive Non-Small Cell Lung Cancer. Cancer Lett Meng X, Bi N, Wang J, Meng X, Wang J, Xing L, Cheng Y, Lu S, Chen M, Yu J, Chinese Society of Clinical Oncology (CSCO) Radiation Therapy Expert Committee, Consensus Expert Group. PMID: 41419100 [PubMed - as supplied by publisher]
	Optimizing adjuvant therapy under the guidance of MPR: A multicenter retrospective analysis of neoadjuvant therapy in non-small cell lung cancer. Eur J Surg Oncol Chen C, Chen J, Huang J, He LP, Shen YM, Tu JH, Lian LY, Jin ZW, Wang HJ, Wang ZJ, Luo YF, Sun ZM, Ye MQ, Shen GY, Xu SJ, Chen SC. PMID: 41418573 [PubMed - as supplied by publisher]
	What is on the Horizon Beyond Platinum and Immunotherapy for Patients With Advanced Non-Small Cell Lung Cancer Without Actionable Genomic Aberrations? JCO Oncol Pract Ribeiro Rangel A, Cavalcante Lima Chagas G, Cavalcante Lima Chagas R, El Osta B. PMID: 41418081 [PubMed - as supplied by publisher]
	Cost-Effectiveness Analysis of Durvalumab in Limited-Stage Small Cell Lung Cancer in the United States. JCO Glob Oncol Jani CT, Manoharan A, Han S, Zheng X, Malik S, Morgenstern-Kaplan D, Salazar AS, Kareff S, Lopes G. PMID: 41418077 [PubMed - indexed for MEDLINE]
	Ablation versus sublobar resection for stage IA non-small cell lung cancer: a multicenter retrospective cohort study using a deep learning model in the ablation group. Int J Surg Xu B, Huang D, Liu D, Huang T, Chen Z, Zhu Z, Lin L, Zhang F. PMID: 41418024 [PubMed - as supplied by publisher]
	A novel prognostic model for lung squamous cell carcinoma based on multi-omics analysis and machine learning. PLoS One Li J, Shen Z, Liu D, Ma J. PMID: 41417784 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 155894

Page 1 of 7795



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy